Stockscreener 앱 받기
0.225
30.77%
-0.10
전일 마감가:
$0.325
열려 있는:
$0.2395
하루 거래량:
442.60K
Relative Volume:
0.05
시가총액:
$7.90M
수익:
$2.63M
순이익/손실:
$-19.13M
주가수익비율:
-0.6276
EPS:
-0.3585
순현금흐름:
$-5.27M
1주 성능:
+93.13%
1개월 성능:
-51.19%
6개월 성능:
-44.99%
1년 성능:
-62.04%
1일 변동 폭
$0.2012
$0.2599
1주일 범위
$0.2012
$0.3989
52주 변동 폭
$0.0827
$0.9078
Osr Health Inc Stock (OSRH) Company Profile
명칭
Osr Health Inc
전화
425-635-7700
주소
10900 NE 4TH STREET, SUITE 2300, BELLEVUE
Compare OSRH vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSRH
Osr Health Inc
|
0.225 | 10.36M | 2.63M | -19.13M | -5.27M | -0.3585 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Osr Health Inc 주식(OSRH)의 최신 뉴스
OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission - ACCESS Newswire
OSR (OSRH) Quarter in Focus: EPS Falls Short of Its Estimate in the Latest Reading; Market Move: Shares Move 20.96% LowerEnergy Earnings Report - vinanet.vn
OSR Health Faces Nasdaq Delisting Risk Due to Non-Compliance - Intellectia AI
Form 8K OSR Holdings Inc For: 19 August By Investing.com - Investing.com Australia
OSR Holdings Faces Nasdaq Delisting, Plans Appeal - TipRanks
OSR Health Received Notice of Delisting - TradingView
Nasdaq to delist OSR Health after bid price compliance failure - Investing.com
OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal - Caledonian Record
OSR Health (OSRH) Stock Forecast & Analyst Ratings - Moomoo
OSR Health(OSRH) Stock Options Chain | Quotes & News - Moomoo
OSR Health Sees Global Shareholder Momentum at Critical Inflection Point - ACCESS Newswire
$OSR Health (OSRH.US)$ Why hiding this details - Moomoo
These stocks are the most active in today's session - ChartMill
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why OSR Health (OSRH) Stock Is Up Today - Quiver Quantitative
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum - Barchart.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
$OSR Health (OSRH.US)$ quick one! i think its probably going up more but im done for the night! GL everyone 🫰🏽 - Moomoo
OSRH Q4 2025 Earnings: Loss Widens 56.86% Above Forecast, Yet Shares Climb 11.66%Forward Guidance Trends - vinanet.vn
OSR Health, Inc. Q2 2026: Revenue $316K, Net loss $(849K), EPS $(0.02) — 10-Q Summary - TradingView
OSR Health (OSRH) cuts losses but faces sharp revenue drop and tight cash - Stock Titan
OSRH Stock Price and Chart — NASDAQ:OSRH - TradingView
OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program - ACCESS Newswire
OSR Health faces Nasdaq delisting deadline, cites licensing talks By Investing.com - Investing.com Australia
OSR Health faces Nasdaq delisting deadline, cites licensing talks - Investing.com
OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development - New Castle News
OSR Health clarifies Nasdaq has not approved shareholder loyalty CVR program - Bitget
Form 8K OSR Holdings Inc For: 10 August By Investing.com - Investing.com Nigeria
OSR Health re-elects board and approves key proposals at annual meeting - Investing.com
OSR Health, Inc. (OSRHW) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 8K OSR Holdings Inc For: 7 August By Investing.com - Investing.com India
OSR Holdings Clarifies Nasdaq Stance on CVR Program - TipRanks
OSR Health clarifies Nasdaq did not endorse CVR program; record date remains Aug 14 - TradingView
News by ACCESS Newswire on TradingView, 2026-08-07 - TradingView
OSR (OSRH) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - marketbeat.com
OSR Health subsidiary completes glioblastoma vaccine analysis By Investing.com - Investing.com Australia
OSR Health subsidiary completes glioblastoma vaccine analysis - Investing.com
Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform - New Castle News
Vaximm Announces VXM01 Glioblastoma Data Publication Plans - ACCESS Newswire
OSR Health says Nasdaq won’t apply price adjustment for loyalty CVR distribution - TradingView
OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment - The Joplin Globe
OSR Health Inc (BLACU:UR): Stock Price, Quote and News - BNN Bloomberg
OSR Holdings Inc (OSRH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OSR Holdings Inc (OSRH) Institutional Confidence - TradingKey
OSR Holdings Inc (OSRH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OSRH|OSR Holdings Inc|Price:0.467|Chg%:+0.021 - TradingKey
OSR Holdings Inc (OSRH) Balance Sheet - TradingKey
OSR Health, Inc. Revenue Breakdown – NASDAQ:OSRH - TradingView
OSRH|OSR Holdings Inc|Price:0.424|Chg%:-0.166 - TradingKey
Osr Health Inc (OSRH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):